CHINA·js4399金沙线集团-品牌官网

Search
CN
CN
Press releases
Home · News · Press releases ·
Press releases

SCROLL DOWN

Announcement of the receipt of the listing notice to
CF PharmTech, Inc.

Jul.25.2022

8530

Share

Back to list
Previous chapter
Good news from CF PharmTech | The first domestic blockbuster product for the treatment of allergic rhinitis - Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (ShuFeiMin ®) was approved
Next chapter
CF PharmTech has completed F round of 360 million yuan equity investment to support rapid development of domestic high-end inhalation products.
XML 地图